Top compounds associated with response to ASNSD1


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.17 2e-06
mRNA Gemcitabine gCSI pan-cancer AAC 0.23 3e-05
mRNA Erlotinib GDSC1000 pan-cancer AAC -0.2 6e-05
mRNA Gefitinib CTRPv2 pan-cancer AAC -0.15 9e-05
mRNA lapatinib GDSC1000 pan-cancer AAC -0.19 0.0001
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.13 0.0002
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0004
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA YM-155 CTRPv2 pan-cancer AAC 0.13 0.0007
mRNA EKB-569 GDSC1000 pan-cancer AAC -0.12 0.0007
Download CSV